| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000030035 |
| Receipt No. | R000033958 |
| Scientific Title | Exploratory research for biomarkers related to Interpersonal Therapy |
| Date of disclosure of the study information | 2017/11/30 |
| Last modified on | 2021/12/11 (Ver. 5) |
| Basic information | ||
| Public title | Exploratory research for biomarkers related to Interpersonal Therapy | |
| Acronym | Exploratory research for biomarkers related to Interpersonal Therapy | |
| Scientific Title | Exploratory research for biomarkers related to Interpersonal Therapy | |
| Scientific Title:Acronym | Exploratory research for biomarkers related to Interpersonal Therapy | |
| Region |
|
|
| Condition | ||
| Condition | depressive disorders, bipolar and related disorders, anxiety disoredrs, post-traumatic stress disorder or feeding and eating disorders | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To explore the relationship between biomarkers assessed by brain MRI,endocrinology and metabolism examination and inflammation markers and psychosocial factors such as social support and clinical symptoms longitudinally and cross-sectionally on patients taken interpersonal therapy with diagnosis of depressive disorders, anxiety disorders, PTSD or eating disorders. |
| Basic objectives2 | Bio-equivalence |
| Basic objectives -Others | |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | Beck Depression Inventory Second Edition
The Self report Version of the Panic Disorder Severity Scale The Liebowitz Social Anxiety Scale Self Report Posttraumatic Diagnostic Scale Eating Disorder Inventory |
| Key secondary outcomes | |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1. The Diagnosis is Depressive Disorders" or "Bipolar and Related Disorders" or "Anxiety Disoredrs" or "Post-traumatic stress disorder" or "Feeding and Eating disorders"for DSM-5. "Major Depressive Disorder", "Bipolar Disorder", "Panic Disorder", "Social Anxiety Disorder", "Post-traumatic Stress Disorder", "Anorexia Nervosa", "Bulimia Nervosa", "Binge Eating Disorder" and "General Anxiety Disorder" have to be assessed by The Mini-International Neuropsychiatric Interview(M.I.N.I.)7.0.0 .
2. The patients has signed an informed consent for intervention study of interpersonal psychotheapy in a month. 3. The patients who can be signed informed concent were enrolled in the present study. |
|||
| Key exclusion criteria | 1. The Diagnosis is "Schizophrenia Spectrum and Other Psychotic Disorders" or Obsessive-compulsive and Related Disorders" or "Cluster APersonality Disorders" or "Antisocial Personality Disorder" or "Neurodevelopmental Disorders" or "Neurocognitive disorders"
2. The patients who have active suicidal thought. 3. The patients who have any history of physical diseases or body condition that may prevent the study. 4.Patients who cannot be scanned with MRI safely because they has medical devices such as cardiac pacemakers, cochlear implants, or other metallic implants. 5. The patients who their research doctor consider not suited. |
|||
| Target sample size | 50 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Nagoya City University | ||||||
| Division name | Division of Psychiatry and Cognitive-Behavioral Medicine | ||||||
| Zip code | |||||||
| Address | Kawasumi 1, Mizuho-cho, Mizuho-ku, Nagoya | ||||||
| TEL | 052-851-5511 | ||||||
| kondo-masaki@umin.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Nagoya City University | ||||||
| Division name | Division of Psychiatry and Cognitive-Behavioral Medicine | ||||||
| Zip code | |||||||
| Address | Kawasumi 1, Mizuho-cho, Mizuho-ku, Nagoya | ||||||
| TEL | 052-851-5511 | ||||||
| Homepage URL | |||||||
| imai.r.nagoya@gmail.com | |||||||
| Sponsor | |
| Institute | Nagoya City University |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Ministry of Education, Culture, Sports, Science and Technology |
| Organization | |
| Division | |
| Category of Funding Organization | Japanese Governmental office |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | |
| Address | |
| Tel | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | We include patients who consented to the preceding intervention study(UMIN000022841) and conduct tests before and after treatment.
The method of the treatment intervention is stated in the preceding study protocol. Test before treatment Brain MRI Blood test:metabolic functions, thyroid functions, vitamins, trace elements, ferritin Test before and after treatment Inflammation markers, cortisol WCST:Wisconsin Card Sorting Test |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000033958 |